Literature DB >> 12388101

Coordinate upregulation of guanylin and uroguanylin expression by hypertonicity in HT29-18-N2 cells.

Kris A Steinbrecher1, Jeffrey A Rudolph, Guangju Luo, Mitchell B Cohen.   

Abstract

Guanylin and uroguanylin are particulate guanylate cyclase-activating peptides that are secreted from the epithelia of the intestine, kidney, pancreas, and salivary gland. These peptides elicit chloride and bicarbonate secretion via the cystic fibrosis transmembrane conductance regulator. To test the hypothesis that hypertonicity mediates an increase in guanylin and uroguanylin mRNA, we subjected HT29-18-N2 to osmotic stress. Guanylin and uroguanylin RNA were increased substantially in the presence of hypertonicity but only with solutes that were relatively impermeable to the cell membrane. This hypertonicity-mediated increase was transcriptional and did not require protein synthesis. Herbimycin A and mitogen-activated protein kinase inhibitors SB-203580 and PD-98059 had no effect on basal or induced levels of guanylin or uroguanylin. Both staurosporine and prolonged exposure to phorbol ester reduced basal levels and completely blocked hypertonicity-related increases in guanylin or uroguanylin RNA. These data suggest that serine/theonine protein kinases, possibly protein kinase C (PKC), mediate the hypertonicity-associated increase in guanylin and uroguanylin RNA. We conclude that guanylin and uroguanylin are released in response to hypertonic stress and that regulation of these genes may be mediated by PKC isoforms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388101     DOI: 10.1152/ajpcell.00010.2002

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  6 in total

1.  cGMP Signaling Increases Antioxidant Gene Expression by Activating Forkhead Box O3A in the Colon Epithelium.

Authors:  Rui Wang; Bianca N Islam; Allison Bridges; Sarah K Sharman; Muhan Hu; Yali Hou; Payaningal R Somanath; Laine Venable; Nagendra Singh; Sangmi Kim; Subbaramiah Sridhar; Franz Hofmann; Darren D Browning
Journal:  Am J Pathol       Date:  2016-12-18       Impact factor: 4.307

Review 2.  Pendrin, a novel transcriptional target of the uroguanylin system.

Authors:  Julia Rozenfeld; Osnat Tal; Orly Kladnitsky; Lior Adler; Edna Efrati; Stephen L Carrithers; Seth L Alper; Israel Zelikovic
Journal:  Cell Physiol Biochem       Date:  2013-12-18

3.  Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.

Authors:  Nicholas G Moss; Robert C Fellner; Xun Qian; Sharon J Yu; Zhiping Li; Masamitsu Nakazato; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

Review 4.  Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis.

Authors:  Giovanni M Pitari
Journal:  Drug Des Devel Ther       Date:  2013-04-19       Impact factor: 4.162

5.  Guanylate cyclase C deficiency causes severe inflammation in a murine model of spontaneous colitis.

Authors:  Eleana Harmel-Laws; Elizabeth A Mann; Mitchell B Cohen; Kris A Steinbrecher
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

6.  Dietary salt regulates uroguanylin expression and signaling activity in the kidney, but not in the intestine.

Authors:  Robert C Fellner; Nicholas G Moss; Michael F Goy
Journal:  Physiol Rep       Date:  2016-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.